Arrowstreet Capital, Limited Partnership Pacira Bio Sciences, Inc. Transaction History
Arrowstreet Capital, Limited Partnership
- $122 Billion
- Q4 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 647,318 shares of PCRX stock, worth $16.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
647,318
Previous 1,152,625
43.84%
Holding current value
$16.9 Million
Previous $17.4 Million
29.74%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding PCRX
# of Institutions
260Shares Held
49.8MCall Options Held
1.03MPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$208 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$137 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$85 Million0.15% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$58.8 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$51.9 Million0.06% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.19B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...